Karl Herrup, author of How Not to Study a Disease: The Story of Alzheimer’s (2021) speaks about how the field of Alzheimer’s went down the wrong path in the search for a cure, the consequences of the Food and Drug Administration’s (FDA) approval of Aduhelm, and his vision for a new path in studying Alzheimer’s, aging and dementia. We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to support of our mission of giving people impacted by dementia a better resource and connection to experts at the forefront of research. Our audience has grown so rapidly; we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs. https://beingpatient.nationbuilder.com/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related